Clinical Trial Update: Anakinra (Kineret®) in Combination With Disease Modifying Anti-Rheumatic Drugs (DMARDS) in Subjects With Active Rheumatoid Arthritis (RA) [Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 3 study of anakinra (Kineret) in combination with DMARDs in patients with active rheumatoid arthritis. The trial st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• KINERET (ANAKINRA)

Snippet

Sponsor: Amgen | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED